However, variations in background risks and analytical methods ... they would be a one-time vaccination for now. For Pfizer and GSK, RSV vaccines are critical as they seek to build new revenue ...

GlaxoSmithKline chief executive Emma Walmsley ... experience" – which may be an oblique reference to Walmsley's background in consumer health. According to the latter, shareholders "still ...

ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the ...

Prince Harry’s Montecito, California, home was on display in a new video about the 2025 WellChild Awards. The clip, released ...

Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as its Chair Designate. Dr. Slaoui, a notable figure ...

Before taking over the top job from Sir Andrew Witty last April, Walmsley was head of GSK’s consumer business. But despite this background, Walmsley said that the company’s pharmaceuticals ...

AutoGen represents Microsoft’s latest attempt to address the challenges of building multi-agent systems for enterprise applications. This article explores what this means for the state of agentic AI ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Median duration of therapy was 20.5 months for the combination and 16.4 months with single-agent nivolumab. Median number of ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 12.59%, which has investors questioning if this is right time to ...

RICHMOND, VA - Indivior PLC (LON:INDV), a pharmaceutical company specializing in treatments for substance use disorders, ...